<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2018.81001</article-id><article-id pub-id-type="publisher-id">WJCD-81702</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Role of CIMT, eGFR, and Serum HbA1c in Predicting CAD in Non-Diabetic Patients Undergoing Elective Coronary Angiography
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>C.</surname><given-names>Kapil</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>D.</surname><given-names>Rajasekhar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>V.</surname><given-names>Vanjakshamma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>D.</surname><given-names>Kranthichaitanya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>C.</surname><given-names>H. Narendra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Cardiology, Sri Venkateswara Institute of Medical Sciences, Tirupati, India</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>kapilchalla@gmail.com(CK)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>01</month><year>2018</year></pub-date><volume>08</volume><issue>01</issue><fpage>1</fpage><lpage>10</lpage><history><date date-type="received"><day>29,</day>	<month>November</month>	<year>2017</year></date><date date-type="rev-recd"><day>8,</day>	<month>January</month>	<year>2018</year>	</date><date date-type="accepted"><day>11,</day>	<month>January</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background:
   Pre-diabetic state, renal function, atherosclerosis burden are the major predictors for development of coronary artery disease (CAD). Present study aims to analyze the role of carotid intima-media thickness (CIMT), glomerular filtration rate (eGFR) and serum glycosylated hemoglobin (HbA1c) levels in predicting CAD on coronary angiography in non-diabetic patients. <b>Methods:</b> CAD and its severity according to SYNTAX score (SX score) was evaluated in 450 non-diabetic patients hospitalized with acute coronary syndrome or stable angina and underwent coronary angiography. CIMT, eGFR, and serum HbA1c values were obtained during admission. Spearman correlation and linear regression were used in the analysis of the data. Receiver operating characteristic (ROC) curve was constructed to calculate cutoff values, area under curve (AUC), sensitivity and specificity. <b>Results:</b>Statistically significant positive correlation was observed between HbA1c (r: 0.242, p = 0.001); CIMT (r: 0.231, p = 0.001), patient’s age (r: 0.148, p = 0.002) and SX score, whereas eGFR was negatively correlated (r: -0.148, p = 0.002).
   
  On regression analysis
  ,
   CIMT, eGFR, HbA1c and patient’s age collectively predicted 36% of change in the SYNTAX score. Patient’s age &gt; 56 years (AUC
   
  =
   
  0.622), CIMT &gt; 0.86 mm (AUC = 0.642), HbA1c &gt; 6 (AUC = 0.620), eGFR &lt; 92 ml/min/1.73 m<sup>2</sup> (AUC = 0.601) were the cutoff values on ROC curve analysis.
   
  CIMT,
   
  HbA1c had relatively high specificity (88.5%, 90.2% respectively) and eGFR had relatively high sensitivity (71.3%) among the studied variables in predicting CAD in present study. <b>Conclusions:</b> CIMT, HbA1c, eGFR and patient’s age at the time of admission predict CAD in non-diabetic patients undergoing coronary angiography.
 
</p></abstract><kwd-group><kwd>CAD</kwd><kwd> CIMT</kwd><kwd> eGFR</kwd><kwd> HbA1c</kwd><kwd> SYNTAX Score</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Over the last decade, cardiovascular disease (CVD) especially coronary artery disease (CAD) has become the largest cause of death worldwide. Recent estimates suggest that 80 percent of CVD deaths occur in developing countries with substantial contribution from India [<xref ref-type="bibr" rid="scirp.81702-ref1">1</xref>] . In India, the estimated adult prevalence (of the age &gt; 30 year) of CAD is around 8 - 10 percent in urban settings and 3 - 4 percent in rural areas, reflecting a rise of six-fold and two-fold respectively between 1960 and 2000 [<xref ref-type="bibr" rid="scirp.81702-ref2">2</xref>] .</p><p>The incidence of CAD is likely to increase further because of rapid urbanization and its accompanying lifestyle changes, including changes in diet, physical inactivity, drug and alcohol intake, as well as an increase in the prevalence of diabetes mellitus (DM) [<xref ref-type="bibr" rid="scirp.81702-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref4">4</xref>] . A positive association has been reported between the duration of DM and the risk of developing CAD [<xref ref-type="bibr" rid="scirp.81702-ref5">5</xref>] . An independent association between fatal CAD and increasing duration of DM has been shown in men [<xref ref-type="bibr" rid="scirp.81702-ref6">6</xref>] . Some studies suggest that CAD and glycosylated hemoglobin (HbA1c) are predictors of cardiovascular mortality [<xref ref-type="bibr" rid="scirp.81702-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref8">8</xref>] . In community-based studies, decreased glomerular filtration rate (GFR) and proteinuria were both found to be independently associated with CAD [<xref ref-type="bibr" rid="scirp.81702-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref11">11</xref>] . The risk for CAD increases gradually with the decline of GFR [<xref ref-type="bibr" rid="scirp.81702-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref15">15</xref>] . Thus the present study was undertaken to analyze the effects of serum HbA1c, (which is a marker of glycemic status) estimated glomerular filtration rate (eGFR) (which is a marker of microvascular kidney disease secondary to various causes), carotid intima-media thickness (CIMT) in predicting CAD on coronary angiography (CAG).</p></sec><sec id="s2"><title>2. Methodology</title><p>Ethics statement: A written informed consent was taken from the patients after explaining the nature of the study. The study was undertaken after the institutional ethics committee approval dated 1. 6. 2015 with IEC No.462 in 44<sup>th</sup> IEC meeting held in SVIMS, Tirupati.</p><p>Study design: Prospective observational study.</p><p>Study period: July 2015-July 2016.</p><p>Study population: Study population was selected from the population of patients undergoing elective CAG in department of cardiology, Sri Venkateswara Institute of Medical sciences, Tirupati.</p><p>Inclusion criteria: Patients presenting with stable angina as well as acute coronary syndrome (ACS) [USA/NSTEMI/STEMI] and undergoing elective CAG were included in the study population.</p><p>Exclusion criteria: Patients with DM or HbA1c &gt; 6.5%, chronic kidney disease, post CABG/PCI, patients with congenital heart diseases and hemoglobinopathies have been excluded from the study.</p><p>Demographic and clinical data on age, gender, smoking habit, DM, and hypertension (HTN) was obtained at the time of admission. Serum HbA1c, Hemoglobin (Hb), Serum Creatinine (SCr) blood urea (Bur) were measured from the sample drawn at the time of admission. Serum HbA1c was measured by ion exchange chromatography method using BIO-RAD D-10 hemoglobin testing system.</p><p>Estimated glomerular filtration rate (eGFR) was measured by Modification of Diet in Renal Disease (MDRD) equation [<xref ref-type="bibr" rid="scirp.81702-ref16">16</xref>] :</p><p>eGFR ( mL / min / 1 . 73   m 2 ) = 186 &#215; sCr − 1 . 154 &#215; age − 0.203 &#215; 0. 742   ( if   female )</p><p>Carotid intima-media thickness (CIMT): Bilateral common carotid arteries of the subjects were scanned longitudinally with L11-3MHz linear transducer attached to PHILIPS IE 33 machine. Images were obtained from the distal portion of the common carotid artery, 1 - 2 cm proximal to the carotid bulb. Only arterial wall intima-media thickness of the distal 1cm portion of the common carotid artery, just before bifurcation, was measured at end-diastole. The mean of left and right common carotid arteries was used for analysis.</p><p>Coronary artery angiography (CAG): Coronary artery angiography was performed using standard Judkins technique through trans-femoral or trans-radial approach. According to the baseline diagnostic angiogram, each coronary lesion having a stenosis obstructing ≥ 50% of the diameter in vessels ≥1.5 mm was scored separately and these scores were added together to produce the overall SYNTAX score (SX score) which was calculated using the SX score algorithm available on the SYNTAX website. Angiographic analysis was carried out by interventional cardiologist who was blinded to the study protocol.</p><p>Statistical analysis: The continuous and categorical variables were presented as the mean &#177; standard deviation (SD) and proportions respectively. Intergroup differences of continuous variables were analyzed by t-test. Spearman correlation and linear regression were used in the analysis of the data. Receiver operating characteristic (ROC) curve was constructed to calculate cutoff values, area under curve (AUC) sensitivity and specificity. All data was processed using the SPSS version 20 (IBM SPSS, IBM Inc. Armonk, USA) statistical software. A p-value &lt; 0.05 was considered to be significant.</p></sec><sec id="s3"><title>3. Results</title><p>The study population consisted of 450 patients, out of which 79 (17.6%) were female and 371 (82.4%) were male. One third of the patients (30.2%) had hypertension and half of them (50.4%) were smokers. STEMI was seen in 176 patients (39%). On coronary angiography 122 patients (27.1%) had no obstructive coronary disease and CAD was identified in 328 patients (72.9%). Percutaneous coronary intervention (PCI) was done in 258 patients (57.6%) and coronary artery bypass grafting (CABG) was done in 50 patients (11.1%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Mean age of the study population was 52.8 &#177; 10.9 years, mean eGFR was 83.7 &#177; 25.1 ml/min/1.73 m<sup>2</sup>, mean SX score was 9.2 &#177; 9.1 and mean HbA1c was 5.7% &#177; 0.6% (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>In the total study population of 450 subjects, 328 had CAD on coronary angiography, this group was labeled as CAD group and the subjects with no CAD on</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Baseline data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Categorical variables</th><th align="center" valign="middle" >Frequency n = 450 (%)</th></tr></thead><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >o Male</td><td align="center" valign="middle" >371 (82.4)</td></tr><tr><td align="center" valign="middle" >o Female</td><td align="center" valign="middle" >79 (17.6)</td></tr><tr><td align="center" valign="middle" >CAD on angiography</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >o Present</td><td align="center" valign="middle" >328 (72.9)</td></tr><tr><td align="center" valign="middle" >o Absent</td><td align="center" valign="middle" >122 (27.1)</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >136 (30.2)</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle" >228 (50.4)</td></tr><tr><td align="center" valign="middle" >STEMI</td><td align="center" valign="middle" >176 (39)</td></tr><tr><td align="center" valign="middle" >Management</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >o CABG</td><td align="center" valign="middle" >50 (11.1)</td></tr><tr><td align="center" valign="middle" >o PTCA</td><td align="center" valign="middle" >258 (57.6)</td></tr><tr><td align="center" valign="middle" >o Medical management</td><td align="center" valign="middle" >142 (31.6)</td></tr><tr><td align="center" valign="middle" >SYNTAX category</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >o 0</td><td align="center" valign="middle" >122 (27.1)</td></tr><tr><td align="center" valign="middle" >o ≤22</td><td align="center" valign="middle" >280 (62.2)</td></tr><tr><td align="center" valign="middle" >o &gt;22</td><td align="center" valign="middle" >48 (10.6)</td></tr><tr><td align="center" valign="middle" >Continuous variable</td><td align="center" valign="middle" >Mean &#177; SD</td></tr><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >52.8 &#177; 10.9</td></tr><tr><td align="center" valign="middle" >eGFR (ml/min/1.73 m<sup>2</sup>)</td><td align="center" valign="middle" >83.7 &#177; 25.1</td></tr><tr><td align="center" valign="middle" >SCr (mg/dl)</td><td align="center" valign="middle" >0.93 &#177; 0.22</td></tr><tr><td align="center" valign="middle" >BMI (kg/m<sup>2</sup>)</td><td align="center" valign="middle" >23.2 &#177; 3.6</td></tr><tr><td align="center" valign="middle" >CIMT (mm)</td><td align="center" valign="middle" >0.77 &#177; 0.20</td></tr><tr><td align="center" valign="middle" >Hb (gm%)</td><td align="center" valign="middle" >12.7 &#177; 1.9</td></tr><tr><td align="center" valign="middle" >HbA1c (%)</td><td align="center" valign="middle" >5.7 &#177; 0.6</td></tr><tr><td align="center" valign="middle" >Platelet count (lakhs/cm<sup>3</sup>)</td><td align="center" valign="middle" >2.6 &#177; 0.7</td></tr><tr><td align="center" valign="middle" >Bur (mg/dl)</td><td align="center" valign="middle" >26.6 &#177; 9.2</td></tr><tr><td align="center" valign="middle" >EF (%)</td><td align="center" valign="middle" >51.2 &#177; 9.9</td></tr><tr><td align="center" valign="middle" >SX score</td><td align="center" valign="middle" >9.2 &#177; 9.1</td></tr></tbody></table></table-wrap><p>Study population characteristics.</p><p>angiography were considered under Non-CAD group. There was a statistically significant difference in the means of CIMT (0.80 &#177; 0.22, 0.69 &#177; 0.13, p = 0.005), HbA1c (5.7 &#177; 0.5,5.5 &#177; 0.4, p = 0.001), SCr (0.96 &#177; 0.20, 0.86 &#177; 0.20, p = 0.001), eGFR (80.8 &#177; 22.9, 91.3 &#177; 28.9, p = 0.001), and patients age (54.1 &#177; 10.6, 49.2 &#177; 10.7, p = 0.001) among the CAD and Non-CAD groups (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>On Spearman correlation analysis, significant positive correlation was observed between HbA1c (r = 0.242, p = 0.001), CIMT (r = 0.231, p = 0.001), SCr</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of means among CAD and Non-CAD groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >CAD group (n = 328) (Mean &#177; SD)</th><th align="center" valign="middle" >Non-CAD group (n = 122) (Mean &#177; SD)</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" >54.1 &#177;10.6</td><td align="center" valign="middle" >49.2 &#177; 10.7</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >eGFR</td><td align="center" valign="middle" >80.8 &#177; 22.9</td><td align="center" valign="middle" >91.3 &#177; 28.9</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >SCr</td><td align="center" valign="middle" >0.96 &#177; 0.20</td><td align="center" valign="middle" >0.86 &#177; 0.20</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" >23.1 &#177; 3.6</td><td align="center" valign="middle" >23.6 &#177; 3.6</td><td align="center" valign="middle" >0.212</td></tr><tr><td align="center" valign="middle" >CIMT</td><td align="center" valign="middle" >0.80 &#177; 0.22</td><td align="center" valign="middle" >0.69 &#177; 0.13</td><td align="center" valign="middle" >0.005</td></tr><tr><td align="center" valign="middle" >HbA1c</td><td align="center" valign="middle" >5.7 &#177; 0.5</td><td align="center" valign="middle" >5.5 &#177; 0.4</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Hb</td><td align="center" valign="middle" >12.8 &#177; 1.9</td><td align="center" valign="middle" >12.5 &#177; 2.0</td><td align="center" valign="middle" >0.127</td></tr><tr><td align="center" valign="middle" >Platelet count</td><td align="center" valign="middle" >2.60 &#177; 0.75</td><td align="center" valign="middle" >2.60 &#177; 0.74</td><td align="center" valign="middle" >0.694</td></tr></tbody></table></table-wrap><p>(r = 0.202, p = 0.001), patient’s age (r = 0.148, p = 0.002) and CAD, whereas eGFR (r = −0.148, p = 0.002) was negatively correlated with CAD on angiography (<xref ref-type="table" rid="table3">Table 3</xref>). On Linear Regression analysis, CIMT, eGFR, HbA1c and patient’s age were independently predicting CAD on angiography and these variables collectively predicted 36% of change in the SX score (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>Patient’s age &gt; 56 years, (AUC = 0.622), CIMT &gt; 0.86 mm (AUC = 0.642), HbA1c &gt; 6, (AUC = 0.620), eGFR &lt; 92 ml/min/1.73 m<sup>2</sup> (AUC=0.601) were the cutoff values obtained by ROC curve analysis for predicting CAD on coronary angiograph (<xref ref-type="table" rid="table5">Table 5</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>In previous studies HbA1c levels, eGFR and CIMT have been individually correlated with CAD on angiography. In the present study we have analyzed the effect and strength of correlation of these variables with CAD.</p><p>HbA1C and CAD: The mean HbA1c in the CAD patients in the present study is 5.7%, which is statistically different compared to patients with normal coronaries (5.5%) (<xref ref-type="table" rid="table2">Table 2</xref>). Similar findings were reported by Iqra Mehraj et al. in their study on Kashmiri Indians [<xref ref-type="bibr" rid="scirp.81702-ref17">17</xref>] . A study by Selim Ayhan et al. [<xref ref-type="bibr" rid="scirp.81702-ref18">18</xref>] in Turkey population showed the optimal cut-off value of HbA1c to predict severe CAD was 6.5%, with 74.4% sensitivity and 75.1% specificity on ROC curve analysis. A study by En-Zhi Jia et al. [<xref ref-type="bibr" rid="scirp.81702-ref19">19</xref>] in Chinese subjects showed that the optimal cutoff value of HbA1c for predicting CAD was &gt;5.1 with sensitivity and specificities of 72%, 75% respectively. A similar study done on Indians by James</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Spearman correlations</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable vs. SX score</th><th align="center" valign="middle" >R value</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" >0.148</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >SCr</td><td align="center" valign="middle" >0.202</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >eGFR</td><td align="center" valign="middle" >−0.148</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" >−0.036</td><td align="center" valign="middle" >0.447</td></tr><tr><td align="center" valign="middle" >CIMT</td><td align="center" valign="middle" >0.231</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >HbA1c</td><td align="center" valign="middle" >0.242</td><td align="center" valign="middle" >0.001</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Linear regression analysis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Model</th><th align="center" valign="middle" >R</th><th align="center" valign="middle" >R square</th><th align="center" valign="middle" >Adjusted R square</th><th align="center" valign="middle" >Std error of estimate</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.275<sup>a </sup></td><td align="center" valign="middle" >0.076</td><td align="center" valign="middle" >0.074</td><td align="center" valign="middle" >0.685</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.345<sup>b </sup></td><td align="center" valign="middle" >0.119</td><td align="center" valign="middle" >0.115</td><td align="center" valign="middle" >0.670</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.368<sup>c </sup></td><td align="center" valign="middle" >0.135</td><td align="center" valign="middle" >0.130</td><td align="center" valign="middle" >0.664</td></tr></tbody></table></table-wrap><p><sup>a</sup>predictors: (constant), CIMT; <sup>b</sup>predictors: (constant),CIMT, eGFR; <sup>c</sup>predictors: (constant), CIMT, eGFR, HbA1c; Dependant variable: SX score.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> ROC curve analysis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Sensitivity</th><th align="center" valign="middle" >Specificity</th><th align="center" valign="middle" >Criteria</th><th align="center" valign="middle" >AUC</th></tr></thead><tr><td align="center" valign="middle" >Patients age</td><td align="center" valign="middle" >39.6</td><td align="center" valign="middle" >79.5</td><td align="center" valign="middle" >&gt;56 years</td><td align="center" valign="middle" >0.622</td></tr><tr><td align="center" valign="middle" >CIMT</td><td align="center" valign="middle" >38.4</td><td align="center" valign="middle" >88.5</td><td align="center" valign="middle" >&gt;0.86 mm</td><td align="center" valign="middle" >0.642</td></tr><tr><td align="center" valign="middle" >eGFR</td><td align="center" valign="middle" >71.3</td><td align="center" valign="middle" >45.9</td><td align="center" valign="middle" >&lt;92.1 ml/min/m<sup>2</sup></td><td align="center" valign="middle" >0.601</td></tr><tr><td align="center" valign="middle" >HbA1c</td><td align="center" valign="middle" >39.0</td><td align="center" valign="middle" >90.2</td><td align="center" valign="middle" >&gt;6</td><td align="center" valign="middle" >0.620</td></tr></tbody></table></table-wrap><p>Dilley et al. [<xref ref-type="bibr" rid="scirp.81702-ref20">20</xref>] showed that HbA1c was significantly correlated with the prevalence of CAD. In the same study, HbA1c value of &gt;5.6% predicted CAD with sensitivity and specificities of 56%, 67.6% respectively. Similarly in present study HbA1c is independently correlated with presence of CAD on angiography, the observed cutoff value of HbA1c on ROC curve analysis for predicting CAD is 6% with sensitivity 39% and specificity 90% (<xref ref-type="table" rid="table5">Table 5</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>CIMT and CAD: CIMT is a valid marker of early atherosclerosis and thus has the potential to detect CVD in its subclinical phase. Several studies have shown that CIMT is strongly associated with cardiovascular risk factors [<xref ref-type="bibr" rid="scirp.81702-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.81702-ref24">24</xref>] . It possibly reflects the cumulative deleterious effects of various cardiovascular risk factors over time. The Chennai Urban Population Study [<xref ref-type="bibr" rid="scirp.81702-ref21">21</xref>] reported mean IMT values in non-diabetic subjects as 0.74 &#177; 0.14 mm which is in agreement with the mean CIMT value in the present study (0.77 &#177; 0.02). In the Atherosclerosis Risk in Communities (ARIC) study [<xref ref-type="bibr" rid="scirp.81702-ref24">24</xref>] , carotid far-wall IMT was consistently greater in those with clinical cardiovascular disease than in disease-free controls. Visona and colleagues [<xref ref-type="bibr" rid="scirp.81702-ref25">25</xref>] showed that CIMT in CAD patients (1.45 &#177; 0.95) was significantly higher than in controls (0.87 &#177; 0.1; p &lt; 0.005). Hansa et al. [<xref ref-type="bibr" rid="scirp.81702-ref26">26</xref>] reported association of CIMT with CAD and CV risk factors in the Indian population, CIMT measured on each side, was significantly higher in the coronary disease group compared to the controls. In this respect, the results of present study (0.80 &#177; 0.22, 0.69 &#177; 0.13, p &lt; 0.005) (<xref ref-type="table" rid="table2">Table 2</xref>) are in agreement with previous studies showing a significant association between raised CIMT and the presence of CAD.</p><p>In a recent systematic review, most of the studies showed a graded positive relationship between CIMT and angiographically assessed coronary atherosclerosis with correlation coefficients in the order of 0.3 - 0.4 [<xref ref-type="bibr" rid="scirp.81702-ref27">27</xref>] . Similarly in present study there is a significant positive correlation observed between the CIMT and presence of CAD on angiography with a correlation coefficient r = 0.231 (p &lt; 0.001) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>In Framingham study [<xref ref-type="bibr" rid="scirp.81702-ref28">28</xref>] , cut-off value of mean IMT of 0.9 mm predicted the presence of CAD, this is in accordance with the present study, where CIMT value of &gt;0.86 mm is associated with CAD in present study population (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>eGFR and CAD: Renal dysfunction is an independent risk factor for the development of CAD as shown in various studies. In the ARIC study [<xref ref-type="bibr" rid="scirp.81702-ref24">24</xref>] , the level of GFR acted as an independent risk factor for atherosclerotic cardiovascular disease. In a study by Rahman M et al. [<xref ref-type="bibr" rid="scirp.81702-ref12">12</xref>] , a low eGFR independently predicted increased risk for CAD. In the present study eGFR value in CAD patients differed significantly from that of patients with normal coronaries on CAG (80.8 &#177; 22.9, 91.3 &#177; 28.9, p &lt; 0.001),CAD patients tend to have low eGFR (<xref ref-type="table" rid="table2">Table 2</xref>). In a study by Jos’e Pedro L et al. [<xref ref-type="bibr" rid="scirp.81702-ref29">29</xref>] , a relatively weak but significant negative correlation was found between eGFR and CAD burden on angiography (r = −0.26, p = 0.006), this is in agreement with the observed negative correlation of eGFR with CAD in present study (r = −0.148, p &lt; 0.02) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Though the strength of correlation is small, the increase in the HbA1c, CIMT values and decrease in the glomerular filtration rate predicted CAD on angiography as explained by Spearman correlation analysis (<xref ref-type="table" rid="table3">Table 3</xref>). HbA1c, CIMT were shown to have relatively high specificity and eGFR had relatively high sensitivity in predicting CAD in present study (<xref ref-type="table" rid="table5">Table 5</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s5"><title>5. Conclusions</title><p>• CIMT, HbA1c, eGFR and patient’s age at the time of admission predict CAD in non-diabetic patients undergoing coronary angiography.</p><p>• Patients with age more than 56 years, CIMT more than 0.86 mm, HbA1c more than 6%, and eGFR less than 92 ml/min/m<sup>2</sup> are most likely to have obstructive CAD on CAG.</p><p>• CIMT has relatively high specificity for identifying CAD patients.</p></sec><sec id="s6"><title>Cite this paper</title><p>Kapil, C., Rajasekhar, D., Vanjakshamma, V., Kranthichaitanya, D. and Narendra, C.H. (2018) Role of CIMT, eGFR, and Serum HbA1c in Predicting CAD in Non-Diabetic Patients Undergoing Elective Coronary Angiography. World Journal of Cardiovascular Diseases, 8, 1-10. https://doi.org/10.4236/wjcd.2018.81001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.81702-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, R., Joshi, P., Mohan, V., Reddy, K.S. and Yusuf, S. (2008) Epidemiology and Causation of Coronary Heart Disease and Stroke in India. Heart, 94, 16-26. 
https://doi.org/10.1136/hrt.2007.132951</mixed-citation></ref><ref id="scirp.81702-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ajay, V.S. and Prabhakaran, D. (2010) Coronary Heart Disease in Indians: Implications of the INTERHEART Study. Indian Journal of Medical Research, 132, 561-566.</mixed-citation></ref><ref id="scirp.81702-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Misra, A., Nigam, P., Hills, A.P., et al. (2012) Consensus Physical Activity Guidelines for Asian Indians. Diabetes Technology &amp; Therapeutics, 14, 83-98. 
https://doi.org/10.1089/dia.2011.0111</mixed-citation></ref><ref id="scirp.81702-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Deepa, R., Arvind, K. and Mohan, V. (2002) Diabetes and Risk Factors for Coronary Artery Disease. Current Science, 83, 1497-505.</mixed-citation></ref><ref id="scirp.81702-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Castelli, W.P. (1988) Cardiovascular Disease in Women. American Journal of Obstetrics &amp; Gynecology, 158, 1553-1560. 
https://doi.org/10.1016/0002-9378(88)90189-5</mixed-citation></ref><ref id="scirp.81702-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Cho, E., Rimm, E.B., Stampfer, M.J., Willett, W.C. and Hu, F.B. (2002) The Impact of Diabetes Mellitus and Prior Myocardial Infarction on Mortality from All Causes and from Coronary Heart Disease in Men. Journal of the American College of Cardiology, 40, 954-960. https://doi.org/10.1016/S0735-1097(02)02044-2</mixed-citation></ref><ref id="scirp.81702-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Rossing, P., Hougaard, P., Borch-Johnsen, K. and Parving, H.H. (1996) Predictors of Mortality in Insulin Dependent Diabetes: 10 Year Observational Follow Up Study. BMJ, 313, 779-784. https://doi.org/10.1136/bmj.313.7060.779</mixed-citation></ref><ref id="scirp.81702-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Gall, M.A., Borch-Johnsen, K., Hougaard, P., Nielsen, F.S., Parving, H.H. (1995) Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM. Diabetes, 44, 1303-1309. https://doi.org/10.2337/diab.44.11.1303</mixed-citation></ref><ref id="scirp.81702-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., et al. (2003) Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 108, 2154-2169. https://doi.org/10.1161/01.CIR.0000095676.90936.80</mixed-citation></ref><ref id="scirp.81702-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Muntner, P., He, J., Hamm, L., Loria, C. and Whelton, P.K. (2002) Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States. Journal of the American Society of Nephrology, 13, 745-753.</mixed-citation></ref><ref id="scirp.81702-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Foley, R.N., Murray, A.M., Li, S., Herzog, C.A., McBean, A.M. and Eggers, P.W. (2005) Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999. Journal of the American Society of Nephrology, 16, 489-495. 
https://doi.org/10.1681/ASN.2004030203</mixed-citation></ref><ref id="scirp.81702-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Rahman, M., Pressel, S., Davis, B.R., et al. (2006) Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate. Annals of Internal Medicine, 144, 172-180.  
https://doi.org/10.7326/0003-4819-144-3-200602070-00005</mixed-citation></ref><ref id="scirp.81702-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">van der Velde, M., Matsushita, K., Coresh, J., et al. (2011) Lower Estimated Glomerular Filtration Rate and Higher Albuminuria Are Associated with All-Cause and Cardiovascular Mortality. A Collaborative Meta-Analysis of High-Risk Population Cohorts. Kidney International, 79, 1341-1352. https://doi.org/10.1038/ki.2010.536</mixed-citation></ref><ref id="scirp.81702-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Segura, J., Campo, C., Gil, P., et al. (2004) Development of Chronic Kidney Disease and Cardiovascular Prognosis in Essential Hypertensive Patients. Journal of the American Society of Nephrology, 15, 1616-1622.  
https://doi.org/10.1097/01.ASN.0000127045.14709.75</mixed-citation></ref><ref id="scirp.81702-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Knobler, H., Zornitzki, T., Vered, S., et al. (2004) Reduced Glomerular Filtration Rate in Asymptomatic Diabetic Patients: Predictor of Increased Risk for Cardiac Events Independent of Albuminuria. Journal of the American College of Cardiology, 44, 2142-2148. https://doi.org/10.1016/j.jacc.2004.09.006</mixed-citation></ref><ref id="scirp.81702-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. and Roth, D. (1999) A More Accurate Method to Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine, 130, 461-470.  
https://doi.org/10.7326/0003-4819-130-6-199903160-00002</mixed-citation></ref><ref id="scirp.81702-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mehraj, I., et al. (2014) Association of HbA1c with Prevalence and Severity of Coronary Artery Disease in Diabetic and Non-Diabetic Patients in Kashmir. Asian Journal of Science and Technology, 5, 230-232.</mixed-citation></ref><ref id="scirp.81702-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ayhan, S.S., et al. (2012) Glycated Haemoglobin Is Correlated with the Severity of Coronary Artery Disease Independently of Traditional Risk Factors in Young Patients. Polish Journal of Endocrinology, 63, 367-371.</mixed-citation></ref><ref id="scirp.81702-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Jia, E.-Z., et al. (2014) Hemoglobin A1c Risk Score for the Prediction of Coronary Artery Disease in Subjects with Angiographically Diagnosed Coronary Atherosclerosis. Cellular Physiology and Biochemistry, 34, 672-680.  
https://doi.org/10.1159/000363032</mixed-citation></ref><ref id="scirp.81702-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Dilley, J., et al. (2007) Association of A1C with Cardiovascular Disease and Metabolic Syndrome in Asian Indians with Normal Glucose Tolerance. Diabetes Care, 30, 1527-1532. https://doi.org/10.2337/dc06-2414</mixed-citation></ref><ref id="scirp.81702-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Mohan, V., Ravikumar, R., Shanthi Rani, S. and Deepa, R. (2000) Intima-Media Thickness of the Carotid Artery in South Indian Diabetic &amp; Non-Diabetic Subjects: The Chennai Urban Population Study (CUPS). Diabetologia, 43, 494-499.  
https://doi.org/10.1007/s001250051334</mixed-citation></ref><ref id="scirp.81702-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Heiss, G., Sharrett, A.R., Barnes, R., Chambless, L.E., Szklo, M. and Alzola, C. (1991) Carotid Atherosclerosis Measured by B-Mode Ultrasound in Populations: Associations with Cardiovascular Risk Factors in the ARIC Study. American Journal of Epidemiology, 134, 250-256.  
https://doi.org/10.1093/oxfordjournals.aje.a116078</mixed-citation></ref><ref id="scirp.81702-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Kuller, L., Borhani, N., Furberg, C., Gardin, J., Manolio, T., O’Leary, D., et al. (1994) Prevalence of Subclinical Atherosclerosis and Cardiovascular Disease and Association with Risk Factors in the Cardiovascular Health Study. American Journal of Epidemiology, 139, 1164-1179. https://doi.org/10.1093/oxfordjournals.aje.a116963</mixed-citation></ref><ref id="scirp.81702-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Burke, G.L., Evans, G.W., Riley, W.A., Sharrett, A.R., Howard, G., Barnes, R.W., et al. (1995) Arterial Wall Thickness Is Associated with Prevalent Cardiovascular Disease in Middle-Aged Adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke, 26, 386-391. https://doi.org/10.1161/01.STR.26.3.386</mixed-citation></ref><ref id="scirp.81702-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Visona, A., Pesavento, R., Lusiani, L., Bonanome, A., Cernetti, C., Rossi, M., et al. (1996) Intimal Medial Thickening of Common Carotid Artery as Indicator of Coronary Artery Disease. Angiology, 47, 61-66.  
https://doi.org/10.1177/000331979604700109</mixed-citation></ref><ref id="scirp.81702-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Hansa, G., Bhargava, K., Bansal, M., Tandon, S. and Kasliwal, R.R. (2003) Carotid Intima-Media Thickness and Coronary Artery Disease: An Indian Perspective. Asian Cardiovascular and Thoracic Annals, 11, 217-221.  
https://doi.org/10.1177/021849230301100308</mixed-citation></ref><ref id="scirp.81702-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Bots, M.L., Baldassarre, D., Simon, A., de Groot, E., O’Leary, D.H., Riley, W., et al. (2007) Carotid Intima-Media Thickness and Coronary Atherosclerosis: Weak or Strong Relations? European Heart Journal, 28, 398-406.  
https://doi.org/10.1093/eurheartj/ehl482</mixed-citation></ref><ref id="scirp.81702-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Budoff, M. (2011) Atherosclerosis: Should We Use CIMT Testing? New Insights from Framingham. Nature Reviews Cardiology, 8, 615-616.  
https://doi.org/10.1038/nrcardio.2011.144</mixed-citation></ref><ref id="scirp.81702-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Jos’e Pedro, L., et al. (2007) Glomerular Filtration Rate and Coronary Artery Disease Burden in Patients with Acute Coronary Syndrome. Clinical Cardiology, 30, 464-468. https://doi.org/10.1002/clc.20145</mixed-citation></ref></ref-list></back></article>